Association of genetic polymorphisms in GADD45A, MDM2, and p14ARF with the risk of chronic benzene poisoning in a Chinese occupational population

Toxicology and Applied Pharmacology

Volumn 240, Issue 1, 2009, Pages 66-72

  Sun, Pin ^a   Zhang, Zhongbin ^a   Wan, Junxiang ^a   Zhao, Naiqing ^a   Jin, Xipeng ^a   Xia, Zhaolin ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Chronic Benzene Poisoning; Lifestyle; SNPs; Susceptibility

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; PROTEIN MDM2;

ADULT; ARTICLE; CHINESE; CHRONIC BENZENE POISONING; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HUMAN; INTOXICATION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL TOXICOLOGY; RISK ASSESSMENT; RISK FACTOR;

ADOLESCENT; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BENZENE; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; CHRONIC DISEASE; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; OCCUPATIONAL DISEASES; POLYMORPHISM, GENETIC; PROTO-ONCOGENE PROTEINS C-MDM2; RISK FACTORS; TUMOR SUPPRESSOR PROTEIN P14ARF; YOUNG ADULT;

EID: 69749117008     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2009.07.003     Document Type: Article

References (47)

1. Alhopuro P., Ylisaukko-Oja S.K., Koskinen W.J., Bono P., Arola J., Jarvinen H.J., Mecklin J.P., Atula T., Kontio R., Makitie A.A., Suominen S., Leivo I., Vahteristo P., Aaltonen L.M., and Aaltonen L.A. The MDM2 promoter polymorphism SNP309T → G and the risk of uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neck. J. Med. Genet. 42 (2005) 694-698
2. Amin R.P., and Witz G. DNA-protein crosslink and DNA strand break formation in HL-60 cells treated with trans,trans-muconaldehyde, hydroquinone and their mixtures. Int. J. Toxicol. 20 (2001) 69-80
3. Andreoli C., Leopardi P., and Crebelli R. Detection of DNA damage in human lymphocytes by alkaline single cell gel electrophoresis after exposure to benzene or benzene metabolites. Mutat. Res. 377 (1997) 95-104
4. Boley S.E., Wong V.A., French J.E., and Recio L. p53 heterozygosity alters the mRNA expression of p53 target genes in the bone marrow in response to inhaled benzene. Toxicol. Sci. 66 (2002) 209-215
5. Bond G.L., Hu W., Bond E.E., Robins H., Lutzker S.G., Arva N.C., Bargonetti J., Bartel F., Taubert H., Wuerl P., Onel K., Yip L., Hwang S.J., Strong L.C., Lozano G., and Levine A.J. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell 119 (2004) 591-602
6. Chene P. Inhibiting the p53-MDM2 interaction: an important target for cancer therapy. Nat. Rev. Cancer 3 (2003) 102-109
7. Dhulipala V.C., Maddali K.K., Welshons W.V., and Reddy C.S. Secalonic acid D blocks embryonic palatal mesenchymal cell-cycle by altering the activity of CDK2 and the expression of p21 and cyclin E. Birth Defects Res. B. Dev. Reprod. Toxicol. 74 (2005) 233-242
8. Dosemeci M., Yin S.N., Linet M., Wacholder S., Rothman N., Li G.L., Chow W.H., Wang Y.Z., Jiang Z.L., Dai T.R., Zhang W.U., Chao X.J., Ye P.Z., Kou Q.R., Fan Y.H., Zhang X.C., Lin X.F., Meng J.F., Zho J.S., Blot W.J., and Hayes R.B. Indirect validation of benzene exposure assessment by association with benzene poisoning. Environ. Health Perspect. 104 Suppl. 6 (1996) 1343-1347
9. el-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., and Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 75 (1993) 817-825
10. Faiola B., Fuller E.S., Wong V.A., and Recio L. Gene expression profile in bone marrow and hematopoietic stem cells in mice exposed to inhaled benzene. Mutat. Res.-Fundam. Mol. Mech. Mutagen. 549 (2004) 195-212
11. Fornace A.J., Alamo I., and Hollander M.C. DNA damage-inducible transcripts in mammalian-cells. Proc. Natl. Acad. Sci. U. S. A. 85 (1988) 8800-8804
12. Freedman D.A., and Levine A.J. Regulation of the p53 protein by the MDM2 oncoprotein-thirty-eighth G.H.A. Clowes Memorial Award Lecture. Cancer Res. 59 (1999) 1-7
13. Geddert H., Kiel S., Zotz R.B., Zhang J., Willers R., Gabbert H.E., and Sarbia M. Polymorphism of p16 ( INK4A ) and cyclin D1 in adenocarcinomas of the upper gastrointestinal tract. J. Cancer Res. Clin. Oncol. 131 (2005) 803-808
14. Glass D.C., Gray C.N., Jolley D.J., Gibbons C., Sim M.R., Fritschi L., Adams G.G., Bisby J.A., and Manuell R. Leukemia risk associated with low-level benzene exposure. Epidemiology 14 (2003) 569-577
15. Goldstein B.D. Benzene toxicity. Occup. Med. 3 (1988) 541-554
16. Gu S.Y., Zhang Z.B., Wan J.X., Jin X.P., and Xia Z.L. Genetic polymorphisms in CYP1A1, CYP2D6, UGT1A6, UGT1A7, and SULT1A1 genes and correlation with benzene exposure in a Chinese occupational population. J. Toxicol. Environ. Health A 70 (2007) 916-924
17. Harkin D.P., Bean J.M., Miklos D., Song Y.H., Truong V.B., Englert C., Christians F.C., Ellisen L.W., Maheswaran S., Oliner J.D., and Haber D.A. Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. Cell 97 (1999) 575-586
18. Hildesheim J., Bulavin D.V., Anver M.R., Alvord W.G., Hollander M.C., Vardanian L., and Fornace Jr. A.J. Gadd45a protects against UV irradiation-induced skin tumors, and promotes apoptosis and stress signaling via MAPK and p53. Cancer Res. 62 (2002) 7305-7315
19. Hollander M.C., Sheikh M.S., Bulavin D.V., Lundgren K., Augeri-Henmueller L., Shehee R., Molinaro T.A., Kim K.E., Tolosa E., Ashwell J.D., Rosenberg M.P., Zhan Q., Fernandez-Salguero P.M., Morgan W.F., Deng C.X., and Fornace Jr. A.J. Genomic instability in Gadd45a-deficient mice. Nat. Genet. 23 (1999) 176-184
20. Hollander M.C., Kovalsky O., Salvador J.M., Kim K.E., Patterson A.D., Haines D.C., and Fornace Jr. A.J. Dimethylbenzanthracene carcinogenesis in Gadd45a-null mice is associated with decreased DNA repair and increased mutation frequency. Cancer Res. 61 (2001) 2487-2491
21. Hollander M.C., Philburn R.T., Patterson A.D., Wyatt M.A., and Fornace A.J. Genomic instability in Gadd45a(-/-) cells is coupled with S-phase checkpoint defects. Cell Cycle 4 (2005) 704-709
22. Hu Z., Ma H., Lu D., Qian J., Zhou J., Chen Y., Xu L., Wang X., Wei Q., and Shen H. Genetic variants in the MDM2 promoter and lung cancer risk in a Chinese population. Int. J. Cancer 118 (2006) 1275-1278
23. Jin S., Fan F., Fan W., Zhao H., Tong T., Blanck P., Alomo I., Rajasekaran B., and Zhan Q. Transcription factors Oct-1 and NF-YA regulate the p53-independent induction of the GADD45 following DNA damage. Oncogene 20 (2001) 2683-2690
24. Kang M.Y., Lee B.B., Ji Y.I., Jung E.H., Chun H.K., Song S.Y., Park S.E., Park J., and Kim D.H. Association of interindividual differences in p14ARF promoter methylation with single nucleotide polymorphism in primary colorectal cancer. Cancer 112 (2008) 1699-1707
25. Michael D., and Oren M. The p53-Mdm2 module and the ubiquitin system. Semin. Cancer Biol. 13 (2003) 49-58
26. Mucci L.A., Wedren S., Tamimi R.M., Trichopoulos D., and Adami H.O. The role of gene-environment interaction in the aetiology of human cancer: examples from cancers of the large bowel, lung and breast. J. Intern. Med. 249 (2001) 477-493
27. Oliner J.D., Kinzler K.W., Meltzer P.S., George D.L., and Vogelstein B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358 (1992) 80-83
28. Pine S.R., Mechanic L.E., Bowman E.D., Welsh J.A., Chanock S.C., Shields P.G., and Harris C.C. MDM2 SNP309 and SNP354 are not associated with lung cancer risk. Cancer Epidemiol. Biomarkers. Prev. 15 (2006) 1559-1561
29. Price B.D., and Park S.J. DNA damage increases the levels of MDM2 messenger RNA in wtp53 human cells. Cancer Res. 54 (1994) 896-899
30. Seiji K., Jin C., Watanabe T., Nakatsuka H., and Ikeda M. Sister chromatid exchanges in peripheral lymphocytes of workers exposed to benzene, trichloroethylene, or tetrachloroethylene, with reference to smoking habits. Int. Arch. Occup. Environ. Health 62 (1990) 171-176
31. Sherr C.J. Divorcing ARF and p53: an unsettled case. Nat. Rev. Cancer 6 (2006) 663-673
32. Shi Y.Y., and He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 15 (2005) 97-98
33. Smith M.L., Kontny H.U., Zhan Q., Sreenath A., O'Connor P.M., and Fornace Jr. A.J. Antisense GADD45 expression results in decreased DNA repair and sensitizes cells to u.v.-irradiation or cisplatin. Oncogene 13 (1996) 2255-2263
34. Snyder R. Recent developments in the understanding of benzene toxicity and leukemogenesis. Drug Chem. Toxicol. 23 (2000) 13-25
35. Stephens M., and Scheet P. Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am. J. Hum. Genet. 76 (2005) 449-462
36. Stephens M., Smith N.J., and Donnelly P. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68 (2001) 978-989
37. Sun P., Qian J., Zhang Z.B., Wan J.X., Wu F., Jin X.P., Fan W.W., Lu D.R., Zhao N.Q., Christiani D.C., and Xia Z.L. Polymorphisms in phase I and phase II metabolism genes and risk of chronic benzene poisoning in a Chinese occupational population. Carcinogenesis 29 (2008) 2325-2329
38. Venkatachalam S., Shi Y.P., Jones S.N., Vogel H., Bradley A., Pinkel D., and Donehower L.A. Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation. EMBO J. 17 (1998) 4657-4667
39. Vousden K.H. Outcomes of p53 activation-spoilt for choice. J. Cell. Sci. 119 (2006) 5015-5020
40. Wan J., Shi J., Hui L., Wu D., Jin X., Zhao N., Huang W., Xia Z., and Hu G. Association of genetic polymorphisms in CYP2E1, MPO, NQO1, GSTM1, and GSTT1 genes with benzene poisoning. Environ. Health Perspect. 110 (2002) 1213-1218
41. Wang X.W., Zhan Q., Coursen J.D., Khan M.A., Kontny H.U., Yu L., Hollander M.C., O'Connor P.M., Fornace Jr. A.J., and Harris C.C. GADD45 induction of a G2/M cell cycle checkpoint. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 3706-3711
42. Wang Z., Tang L., Sun G., Tang Y., Xie Y., Wang S., Hu X., Gao W., Cox S.B., and Wang J.S. Etiological study of esophageal squamous cell carcinoma in an endemic region: a population-based case control study in Huaian, China. BMC Cancer. 6 (2006) 287
43. Watanabe M., and Yamaguchi K. The EM Algorithm and Related Statistical Models (2004), Marcel Dekker, New York
44. Wilkening S., Bermejo J.L., Burwinkel B., Klaes R., Bartram C.R., Meindl A., Bugert P., Schmutzler R.K., Wappenschmidt B., Untch M., Hemminki K., and Forsti A. The single nucleotide polymorphism IVS1+309 in mouse double minute 2 does not affect risk of familial breast cancer. Cancer Res. 66 (2006) 646-648
45. Wu F., Zhang Z., Wan J., Gu S., Liu W., Jin X., and Xia Z. Genetic polymorphisms in hMTH1, hOGG1 and hMYH and risk of chronic benzene poisoning in a Chinese occupational population. Toxicol. Appl. Pharmacol. 233 (2008) 447-453
46. Zhan Q., Chen I.T., Antinore M.J., and Fornace Jr. A.J. Tumor suppressor p53 can participate in transcriptional induction of the GADD45 promoter in the absence of direct DNA binding. Mol. Cell. Biol. 18 (1998) 2768-2778
47. Zhang Z., Wan J., Jin X., Jin T., Shen H., Lu D., and Xia Z. Genetic polymorphisms in XRCC1, APE1, ADPRT, XRCC2, and XRCC3 and risk of chronic benzene poisoning in a Chinese occupational population. Cancer Epidemiol. Biomarkers Prev. 14 (2005) 2614-2619